Literature DB >> 27933513

Effect of Yiqi Tongyang Decoction () on blood T cell subsets in patients with chronic immune thrombocytopenia.

Xiu-Peng Yang1, Rou Ma1, Xiao-Hong Yang1, Hui-Lan Zhu1, Yong-Gang Xu2.   

Abstract

OBJECTIVE: To measure the proportions of blood T cell subsets, Th1, Th2, Th17, Th22, and Treg cells, and other parameters in patients with chronic immune thrombocytopenia (CITP) before and after treatment with Yiqi Tongyang Decoction (, YTD) to explore T cell status of patients with CITP, and to defifine the mechanism of action of YTD.
METHODS: The changes in peripheral blood T lymphocyte subsets, and those of Th1, Th2, Th17, Th22, and Treg cells in 30 patients with CITP (22 females and 8 males) were analyzed using multiparametric flflow cytometry before and after treatment with YTD for 6 months, and 26 healthy volunteers (14 males and 12 females) acted as a control. T-box expressed in T-cells (T-bet) and GATA binding protein 3 (GATA-3) mRNA levels in patients and controls were analyzed using real-time reverse transcription-polymerase chain reaction.
RESULTS: The proportions of Th1, Th17, Th22, Th1/Th2, and Th17/Treg cells increased in the peripheral blood of patients with CITP compared to those in controls before YTD therapy (P<0.05). Th1 cell numbers and the Th1/Th2 ratio fell in the treated patients with CITP to approximate the values of the control group (P>0.05). Th17 cell numbers and the Th17/Treg ratio also decreased in the treatment group (P<0.05), but not to the levels of the controls. The number of Treg cells in the peripheral blood of patients with CITP before treatment was lower than that in the control group (P<0.05), but increased after YTD treatment P<0.05), but not to the level of controls. T-bet and GATA-3 mRNA levels in peripheral blood were initially higher in patients before treatment than controls (P<0.05), but decreased after YTD therapy (P<0.05).
CONCLUSIONS: Imbalances in T lymphocyte levels, particularly those of Th1/Th2 and Th17/Treg cells, play important roles in the pathogenesis of CITP. YTD effificiently regulated the dynamics of Th1/Th2 and Th17/Treg equilibria.

Entities:  

Keywords:  Chinese medicine; GATA binding protein 3; T-box expressed in T-cells; Th cells; Treg cells; Yiqi Tongyang Decoction; immune thrombocytopenia

Mesh:

Substances:

Year:  2016        PMID: 27933513     DOI: 10.1007/s11655-016-2278-7

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  6 in total

1.  Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia.

Authors:  Yu Hu; Haiyan Li; Lei Zhang; Baozhong Shan; Xingfang Xu; Hong Li; Xinguang Liu; Shuqian Xu; Shuang Yu; Daoxin Ma; Jun Peng; Ming Hou
Journal:  Hum Immunol       Date:  2012-04-23       Impact factor: 2.850

Review 2.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

3.  Abnormality of regulatory T-cells in remission and non-remission idiopathic thrombocytopaenic purpura patients.

Authors:  Hava Üsküdar Teke; Eren Gündüz; Olga Meltem Akay; Zafer Gülbas
Journal:  Platelets       Date:  2012-12-07       Impact factor: 3.862

4.  High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.

Authors:  Yu Wei; Xue-bin Ji; Ya-wen Wang; Jing-xia Wang; En-qin Yang; Zheng-cheng Wang; Yu-qi Sang; Zuo-mu Bi; Cui-ai Ren; Fang Zhou; Guo-qiang Liu; Jun Peng; Ming Hou
Journal:  Blood       Date:  2015-10-19       Impact factor: 22.113

5.  Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis.

Authors:  Athanasia Mouzaki; Maria Theodoropoulou; Ioannis Gianakopoulos; Vassiliki Vlaha; Maria-Christina Kyrtsonis; Alice Maniatis
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

6.  The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia.

Authors:  Lili Ji; Yanxia Zhan; Fanli Hua; Feng Li; Shanhua Zou; Weiguang Wang; Dongli Song; Zhihui Min; Hao Chen; Yunfeng Cheng
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

  6 in total
  1 in total

1.  Elucidation of the Mechanisms and Molecular Targets of Yiqi Shexue Formula for Treatment of Primary Immune Thrombocytopenia Based on Network Pharmacology.

Authors:  Yunyao Jiang; Nan Liu; Shirong Zhu; Xiaomei Hu; Dennis Chang; Jianxun Liu
Journal:  Front Pharmacol       Date:  2019-10-01       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.